Wuhan General Gr Chn
Wuhan General Group (China), Inc., a nutraceutical biotechnology company focused on alternative plant-based cannabinoids and psilocybin medical research. The company offers its products for medical applications, including cancer, mental disorders, chronic pain, and others. Wuhan General Group (China), Inc. is headquartered in Reno, Nevada.
Wuhan General Gr Chn (WUHN) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2022: -0.027x
Based on the latest financial reports, Wuhan General Gr Chn (WUHN) has a cash flow conversion efficiency ratio of -0.027x as of September 2022.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($189.51K) by net assets ($-6.97 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Wuhan General Gr Chn - Cash Flow Conversion Efficiency Trend (2008–2021)
This chart illustrates how Wuhan General Gr Chn's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Wuhan General Gr Chn Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Wuhan General Gr Chn ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
199290
KO:199290
|
N/A |
|
International Steels Ltd
KAR:ISL
|
-0.010x |
|
NXNT
OTCQB:NXNT
|
N/A |
|
Checkit PLC
LSE:CKT
|
-0.132x |
|
Thanh Thai Group JSC
VN:KKC
|
N/A |
|
Novonix Limited
BE:GC3
|
-0.046x |
|
Develop North PLC
LSE:DVNO
|
0.023x |
|
DOLPHIN CAP INVEST
BE:D5S
|
N/A |
Annual Cash Flow Conversion Efficiency for Wuhan General Gr Chn (2008–2021)
The table below shows the annual cash flow conversion efficiency of Wuhan General Gr Chn from 2008 to 2021.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2021-12-31 | $577.37K | $-1.66 Million | -2.876x | -2866.42% |
| 2020-12-31 | $506.86K | $52.70K | 0.104x | -80.49% |
| 2019-12-31 | $-575.33K | $-306.55K | 0.533x | +361.62% |
| 2012-12-31 | $107.33 Million | $-21.86 Million | -0.204x | -179.53% |
| 2011-12-31 | $117.58 Million | $-8.57 Million | -0.073x | -195.51% |
| 2010-12-31 | $112.32 Million | $8.57 Million | 0.076x | +150.80% |
| 2009-12-31 | $102.66 Million | $-15.42 Million | -0.150x | -183.77% |
| 2008-12-31 | $93.59 Million | $16.78 Million | 0.179x | -- |